Table 3 The contribution of P.aeruginosa strain in the individual clinical forms of DA-HAIs (VAP, UTI, CLA-BSI). Data are presented as numbers
Year | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2011–2019 |
|---|---|---|---|---|---|---|---|---|---|---|
No of VAP | 67 | 57 | 35 | 43 | 56 | 56 | 70 | 74 | 35 | 493 |
No of VAP-Pseudomonas | 11 | 12 | 5 | 7 | 7 | 4 | 11 | 6 | 6 | 69 |
No of UTI | 41 | 34 | 29 | 28 | 24 | 34 | 42 | 42 | 25 | 299 |
No of UTI Pseudomonas | 5 | 5 | 2 | 5 | 4 | 1 | 3 | 4 | 3 | 32 |
No of CLA-BSI | 19 | 24 | 16 | 10 | 6 | 10 | 9 | 20 | 13 | 127 |
No of CLA-BSI Pseudomonas | 4 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 7 |